BB Biotech Ventures is a private equity general partner firm.
Ultra-rapid Point-Of-Care molecular diagnostics company Atlas Genetics has raised $35m in Series D from Novartis Venture Funds and others.
Aleva Neurotherapeutics, a Swiss developer of next-generation implants for deep brain stimulation, has collected $18m in a Series C round.
Atlas Genetics, which develops diagnostic tests for infectious diseases, raised $20m in Series C funding from BB Biotech Ventures and others
Read more news concerning BB Biotech Ventures
A sampling of BB Biotech Ventures portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?